Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

AMD stock is down nearly 50%, but explosive growth in AI, gaming, and data centers could make it one of 2025's biggest ...

Stocks are being undercut by trade tensions and concerns about the fiscal outlook.  Comments today from President Trump knocked Apple’s shares down more than -2% and weighed on technology stocks when ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...